Leveraging Cloud Technology for Biotechnology Innovations

Business Intelligence and Analytics Software based on AWS

A prominent international biotechnology company overhauls its GxP-relevant Tableau System to AWS cloud with a scalable, secure, and cost-effective solution that adhere to stringent biopharmaceutical regulations.

Shot of a young scientist conducting an experiment in a laboratory

About the customer

Our client is a global biotechnology leader committed to innovating in the field of active immunotherapies for a tailored treatment of serious diseases. The company has earned international acclaim for their significant contribution to the development of a unique immunization technology that played a key role in addressing a worldwide health emergency. Beyond this notable achievement, their broad range of products includes targeted cancer treatments, solutions for infectious diseases, and cutting-edge regenerative medicine.

The challenge

Our client was faced with the complex task of migrating their existing GxP-relevant Tableau System into the AWS cloud. This move was crucial in their strategic shift towards a more scalable, secure, and cost-effective cloud-based infrastructure. The challenge lay not only in the technical aspects of the migration but also in ensuring compliance with the strict regulatory standards associated with handling and processing biotech data.

The client needed to maintain the integrity, security, and accessibility of their critical data during and after the migration. Furthermore, it aimed to enhance system performance and efficiency without disrupting its ongoing research and operations. To navigate this intricate process, the client asked for the expertise of valantic Software & Technology Innovations GmbH as a certified AWS advanced partner to support.

The solution

valantic, leveraging the AWS Migration Acceleration Program (MAP), provided a comprehensive solution to the client’s challenge. The process was divided into three phases: “Assess”, “Mobilize”, and “Migrate and Modernize”.

Diagram of the target architecture

The result

Partnering with valantic opened a significant opportunity for the client. This collaboration enabled the client to successful migrate their Tableau environment. Executed in an efficient and highly performant manner, the migration adhered to all necessary best practices and stringent GxP standards. This ensured not only a seamless transition to the cloud but also the preservation of data integrity and system functionality throughout the process.

The migration project successfully yielded a stable, functional, fully qualified, and validated environment that remains compliant with pharmaceutical health standards. This outcome serves as a testament to the effectiveness of the implemented strategies. The new cloud-based infrastructure significantly enhanced system performance and reliability, providing a robust platform for the client’s critical operations. Moreover, the move to the cloud aligns with the client’s strategic goals, offering scalability and flexibility for future growth. The successful partnership with valantic and the transition to AWS has positioned the client to better navigate the digital landscape, underscoring the value of their cloud strategy. In doing so, the client plans to increasingly rely on AWS services and valantic’s cloud expertise.

Your Contact

Dr. Robert Klimke, Director Advanced Cloud Solutions bei valantic Software & Technology Innovations

Dr. Robert Klimke

Director Advanced Cloud Solutions

valantic Software & Technology Innovations